Are RTX Corporation and Northrop Grumman Ready to Break Out?

Key Points

• RTX and Northrop Grumman reported record Q3 backlogs and raised earnings guidance, signaling strong long-term revenue visibility despite margin pressures.
• Both companies generated robust free cash flow exceeding $3 billion combined, supporting safe dividend yields and improving balance sheet strength.
• Analysts see high-teens upside for both stocks, with Northrop poised for a stronger recovery after a sharper pullback than RTX.

Defense stocks RTX NYSE: RTX and Northrop Grumman NYSE: NOC are facing headwinds, including margin pressures and the impact of government interest in their operations. While share buybacks are largely paused amid this scrutiny and the risk of lost contracts, these concerns may already be priced in, shifting attention to the companies' fundamental growth drivers. They include the need to replenish depleted stockpiles, ongoing conflicts, modernization, and increased government spending, all of which point to multi-year cycles for leading defense original equipment manufacturers (OEMs).

Q3 reports in the defense sector revealed record backlogs. RTX, the larger of the two with a more diversified business, reported $340 billion in backlog, underpinned by a recently awarded Tomahawk missile contract. Northrop’s 1.5x book-to-bill ratio also reflects strong order volume. The takeaway for investors is that these companies have clear visibility into long-term revenue growth and earnings quality, and the potential to resume or accelerate buybacks next year.

Defense Stocks Outperform in Q3, Raise Guidance, Strengthen Balance Sheets

Defense stocks had a decent Q3, with revenue growth in the high-single-digit to low-double-digit range. RTX grew by 11.1%, outpacing its smaller rival by more than 400 basis points, but both companies revealed strengths. Broad-based demand drove growth across commercial and defense applications, with the only weakness being tepid growth in Northrop’s space and missile businesses.

Margin was another strength. Both companies reported strong bottom-line results, outperforming estimates on core improvements and revenue leverage.

More importantly, free cash flow looks robust, totaling more than $3 billion between the two companies, sufficient to sustain dividend payments while improving balance sheet health. Dividends are the primary return, yielding 1.5% (RTX) and 1.8% (Northrop Grumman), and arguably safe at less than 50% of the earnings outlook.

The earnings outlook is a catalyst for this pair. Both raised guidance, lifting their earnings outlook above the consensus estimates. Business momentum is present and expected to continue for the foreseeable future, underpinning a healthy cash flow outlook despite market misgivings.

These companies can sustain outperformance in this environment, setting the stage for a persistently bullish revision cycle among analysts.

Analysts Praise Defense Stocks, Reaffirm Upside Potential

Analysts' sentiment trends contributed to stock price corrections for RTX and Northrop in early fall, as price targets had softened over the summer. However, those corrections were a market overreaction, and the stocks were left at discounted levels in late October.

The market response to the companies' Q3 results reveals renewed confidence in long-term growth and profit trajectories, and capital returns alongside them. As it stands, both RTX and NOC have high-teens upside to consensus, but offer different opportunities for investors.

Where RTX’s correction was more of a pause within an uptrend, leaving it in a position to hit fresh highs, NOC's is more of a recovery story—with potential for far more upside. It significantly underperformed its peers during the defense-stock pullback due to company-specific factors. However, Northrop's earnings report rendered factors such as lost contracts moot by revealing strength in orders and backlog. Its stock looks poised to stage a full recovery.

Balance sheet highlights reflect the strength of these companies' positions; cash positions are strong, assets are growing, debt is falling, and equity is rising. The difference is that Northrop grew equity by 10%, nearly double RTX's pace, and its share count is declining. Down significantly from the prior year, Northrop Grumman’s buybacks were enough to reduce its share count while improving equity, providing a dual lever for its share price rebound.

NOC price action advanced by 5% following the release, confirming support near $515. The move marks the second of two bottoms, possibly a double bottom reversal pattern, with the potential to reach $595 before year’s end. Other factors supporting the rebound include MACD and stochastic divergences, coupled with emerging buy signals that add up to a strong bottom. The risk is that the market enters a range and stays trapped until more news is available, but this is unlikely given the trends.

Northrop Grumman’s biggest risk is exposure to fixed-price contracts such as the B-21 Stealth Bomber. They threaten to squeeze margins through cost overruns and may impair future price action. RTX’s more diversified business is less exposed to this problem—its biggest risks are tied to its commercial business. Cyclicality and lawsuits cloud the outlook.